SECTION I: TECHNOLOGICAL KNOW-HOW
SECTION II: MARKETING TACTICS
SECTION III: STRATEGIC DIRECTION
SIMILAR MARKET STUDIES
Summary Affimed Therapeutics AG (Affimed) is a clinical stage biotechnology company. The company develops exclusive antibody therapeutics to treat life threatening diseases such as cancer, besides inflammation. Its products include AFM13 in Phase I trials for the treatment of Hodgkin’s lymphoma; and AFM11 in late formal pre-clinical development for the treatment ...
March 2016 | $250 | View Details >>
Summary LiPlasome Pharma ApS (LiPlasome Pharma), a subsidiary of VECATA A/S is a biotechnology company that develops and commercializes a novel lipid based prodrug and drug delivery platform. The company develops a liplasomal reformulation of anticancer drugs on the market to provide treatment to cancer patients with fewer side effects. Its ...
September 2016 | $250 | View Details >>
Notes: Sales, means the sales volume of Indomethacin Revenue, means the sales value of Indomethacin This report studies sales (consumption) of Indomethacin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Xinhua Pharma Hotai Pharma Konch Pharma Kanglilai (Chem) Industry Co.,LTD Ouyi ...
December 2016 | $3800 | View Details >>
Alpha-2C Adrenergic Receptor (Alpha-2 Adrenergic Receptor Subtype C4 or Alpha-2C Adrenoreceptor or ADRA2C or ADRA2RL2) - Pipeline Review, H1 2016 Summary Global Markets Directs, Alpha-2C Adrenergic Receptor (Alpha-2 Adrenergic Receptor Subtype C4 or Alpha-2C Adrenoreceptor or ADRA2C or ADRA2RL2) - Pipeline Review, H1 2016, provides in depth analysis on Alpha-2C Adrenergic Receptor ...
June 2016 | $3500 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research